Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Metabolic Syndrome

medroxyprogesterone acetate has been researched along with Metabolic Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, Y; Gao, L; Sun, A; Wang, Y; Xue, W; Zheng, T; Zuo, H1
Curb, JD; Manson, JE; Martin, LW; Phillips, L; Stefanick, M; Trevisan, M; Wild, RA; Wu, C1
Gram, J; Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO1
Hitchcock, CL; Kalyan, S; Prior, JC; Pudek, M; Sirrs, S1
Kuhl, H; Stevenson, J1

Trials

4 trial(s) available for medroxyprogesterone acetate and Metabolic Syndrome

ArticleYear
Efficacy and safety evaluation of Cimicifuga foetida extract in menopausal women.
    Climacteric : the journal of the International Menopause Society, 2018, Volume: 21, Issue:1

    Topics: Beijing; Cimicifuga; Estradiol; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Metabolic Syndrome; Middle Aged; Phytotherapy; Plant Extracts; Progesterone; Prospective Studies; Severity of Illness Index; Treatment Outcome

2018
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Menopause (New York, N.Y.), 2013, Volume: 20, Issue:3

    Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Hysterectomy; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Odds Ratio; Placebos; Postmenopause; Risk Factors; Women's Health

2013
The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6

    Topics: Blood Pressure; Body Composition; C-Peptide; Cardiovascular Diseases; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Norpregnenes; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides

2008
Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Pharmacotherapy, 2010, Volume: 30, Issue:5

    Topics: Adipose Tissue; Adult; Body Mass Index; Cardiovascular Diseases; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Hysterectomy; Inflammation Mediators; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Ovariectomy; Progestins; Risk Factors; Serum Albumin

2010

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Metabolic Syndrome

ArticleYear
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:6

    Topics: Aged; Body Mass Index; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Women's Health

2006